Ledger.Open graph →
SEC Form D · filed September 25, 2013

Artax Biopharma, Inc

Offering
$2.0M
Sold
$1.3M
Exemption
Rule 506(c)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (6)

Karim Fadel · Cambridge, MAExec · DirectorTwo Sigma Principals, LLC · New York, NYDirectorKathryn A. Hall · San Francisco, CAExecAntonio Sierra · Washington, Washington, D.C.ExecTwo Sigma Investments, LLC · NEW YORK, NYExec · DirectorMatthew W. Clary · CHICAGO, ILDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗